Emcure Pharmaceuticals Ltd.
EMCUREHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 18 | 9 | 9 quarter-ends |
| Annual reports | 2 | 2 | identity graded |
| Earnings calls | 11 | 9 | transcripts and analyst meets only |
| Shareholding | 9 | 9 | |
| Related party | 1 | 1 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
7 transcript(s)/analyst meet(s) served; 2 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 7 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20240819 | 2024-06-30 | yes | |
| DUPLICATE | 20240819 | 2024-06-30 | no | |
| TRANSCRIPT | 20241113 | 2024-09-30 | yes | |
| DUPLICATE | 20241113 | 2024-09-30 | no | |
| TRANSCRIPT | 20250211 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250528 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250813 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251117 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260210 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260511 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260812 | 2026-06-30 | yes |